LUCARELLI, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 761
AS - Asia 429
EU - Europa 374
AF - Africa 18
SA - Sud America 5
OC - Oceania 1
Totale 1.588
Nazione #
US - Stati Uniti d'America 749
SG - Singapore 221
IT - Italia 140
HK - Hong Kong 88
NL - Olanda 62
VN - Vietnam 56
GB - Regno Unito 50
CN - Cina 44
RU - Federazione Russa 43
DE - Germania 28
CI - Costa d'Avorio 18
CA - Canada 11
FI - Finlandia 10
IN - India 10
AT - Austria 8
FR - Francia 7
BR - Brasile 4
DK - Danimarca 4
UA - Ucraina 4
IE - Irlanda 3
IR - Iran 3
LT - Lituania 3
SE - Svezia 3
CZ - Repubblica Ceca 2
AM - Armenia 1
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
GE - Georgia 1
HR - Croazia 1
IL - Israele 1
IM - Isola di Man 1
KG - Kirghizistan 1
KR - Corea 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PL - Polonia 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 1.588
Città #
Singapore 151
Chandler 126
Hong Kong 88
Ashburn 76
Naples 63
Santa Clara 60
Amsterdam 58
Dong Ket 56
Enfield 41
Millbury 31
Lawrence 24
Des Moines 22
Boston 15
Phoenix 12
Ottawa 11
Frankfurt am Main 10
Helsinki 10
Beijing 9
Napoli 9
Seattle 9
Milan 8
Wilmington 8
Los Angeles 6
Nuremberg 6
Council Bluffs 5
Fairfield 5
Kronberg 5
Nanjing 5
Princeton 5
Pune 4
Siziano 4
Vienna 4
Woodbridge 4
Augusta 3
Boardman 3
Dearborn 3
Dublin 3
Hebei 3
Marijampolė 3
Moscow 3
Redwood City 3
Rome 3
Salerno 3
Shanghai 3
Abidjan 2
Cambridge 2
Cardiff 2
Changsha 2
Dalmine 2
Houston 2
Jiaxing 2
Kolkata 2
Locate di Triulzi 2
Paris 2
Piana 2
Romainville 2
Rovereto 2
Washington 2
Wuhan 2
Afragola 1
Alba 1
Ambrolauri 1
Ardabil 1
Bishkek 1
Bitonto 1
Bratislava 1
Brno 1
Brussels 1
Buffalo 1
Bungarribee 1
Burgas 1
Campo Belo do Sul 1
Cesena 1
Dallas 1
Douglas 1
Edinburgh 1
Florence 1
Goiânia 1
Groningen 1
Guangzhou 1
Kathmandu 1
Kyiv 1
Lima 1
Lisbon 1
Manassas 1
Mugnano Di Napoli 1
Mugnano di Napoli 1
Nanchang 1
Natal 1
New York 1
Newark 1
Norwalk 1
Osnago 1
Padova 1
Prague 1
Shenyang 1
Shijiazhuang 1
Somma Vesuviana 1
Stockholm 1
São Paulo 1
Totale 1.054
Nome #
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets 111
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials 63
Epigenetic signature: A new player as predictor of clinically significant prostate cancer (PCa) in patients on active surveillance (AS) 56
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis 56
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 54
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 54
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives 53
Beyond PSA: The Role of Prostate Health Index (phi) 48
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 46
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 45
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 44
Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis 44
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 43
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 43
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer 42
Integration of lipidomics and transcriptomics reveals reprogramming of the lipid metabolism and composition in clear cell renal cell carcinoma 40
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 39
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 39
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 36
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy 36
SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study 36
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 36
Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review 35
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings 35
The Impact of Meat Intake on Bladder Cancer Incidence: Is It Really a Relevant Risk? 34
Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers 34
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer 34
Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies 34
Liquid biopsy biomarkers in urine: A route towards molecular diagnosis and personalized medicine of bladder cancer 32
Prostate cancer radiogenomics—from imaging to molecular characterization 32
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin Immunotherapy 31
The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial 30
Surgical blood loss during holmium laser enucleation of the prostate (HoLEP) is not affected by short-term pretreatment with dutasteride: a double-blind placebo-controlled trial on prostate vascularity 30
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 28
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer 23
Current Management of Urachal Carcinoma: An Evidence-based Guide for Clinical Practice 21
Novel Key Ingredients in Urinary Tract Health-The Role of D-mannose, Chondroitin Sulphate, Hyaluronic Acid, and N-acetylcysteine in Urinary Tract Infections (Uroial PLUS®) 19
Radiomics in prostate cancer: an up-to-date review 18
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice 18
Quality of Web-Based Patient Information on Robotic Radical Cystectomy Remains Poor: A Standardized Assessment 17
Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer 16
Molecular Imaging Diagnosis of Renal Cancer Using 99mTc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques 16
Radiogenomics in Renal Cancer Management-Current Evidence and Future Prospects 14
Percutaneous Ablation vs Robot-Assisted Partial Nephrectomy for Completely Endophytic Renal Masses: A Multicenter Trifecta Analysis with a Minimum 3-Year Follow-Up 13
Radiotherapy to the Primary Tumor: The First Step of a Tailored Therapy in Metastatic Prostate Cancer 13
Microwave versus cryoablation and radiofrequency ablation for small renal mass: a multicenter comparative analysis 13
The evolving landscape of renal surgery for complex renal masses (CRM): implications for oncologic and functional outcomes 9
Totale 1.663
Categoria #
all - tutte 9.520
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.520


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202023 0 0 0 0 0 0 0 0 5 4 8 6
2020/2021117 5 0 1 3 1 13 2 1 18 7 4 62
2021/2022189 7 3 4 0 2 2 1 3 6 22 70 69
2022/2023436 29 11 16 7 50 38 1 41 60 128 53 2
2023/2024290 6 55 60 22 16 15 5 38 5 2 51 15
2024/2025559 64 80 0 11 53 61 160 88 42 0 0 0
Totale 1.663